(Q37738780)

22 August 2017

1 reference

title

PPARs in bone: the role in bone cell differentiation and regulation of energy metabolism (English)

1 reference

22 August 2017

1 reference

Beata Lecka-Czernik

1

1 reference

22 August 2017

publication date

1 June 2010

1 reference

Current osteoporosis reports

22 August 2017

published in

1 reference

22 August 2017

volume

8

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

84-90

1 reference

Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11914-010-0016-1

PPARgamma in human and mouse physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-010-0016-1

PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-010-0016-1

PPARgamma2 Regulates a Molecular Signature of Marrow Mesenchymal Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-010-0016-1

PPAR Gamma Activity and Control of Bone Mass in Skeletal Unloading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-010-0016-1

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-010-0016-1

The important role of lipid peroxidation processes in aging and age dependent diseases

21 January 2018

1 reference

12 December 2020

Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone).

1 reference

12 December 2020

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

1 reference

12 December 2020

Skeletal consequences of deletion of steroid receptor coactivator-2/transcription intermediary factor-2.

1 reference

12 December 2020

Playing with bone and fat.

1 reference

12 December 2020

Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways

1 reference

12 December 2020

Marrow adipose cells and hemopoiesis: an interpretative review

1 reference

12 December 2020

Differential expression of cytokines in subcutaneous and marrow fat of aging C57BL/6J mice

1 reference

12 December 2020

Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis

1 reference

12 December 2020

Endocrine regulation of energy metabolism by the skeleton

1 reference

12 December 2020

Mechanisms of disease: is osteoporosis the obesity of bone?

1 reference

12 December 2020

Resolving the Two "Bony" Faces of PPAR-gamma.

1 reference

12 December 2020

PPAR-gamma regulates osteoclastogenesis in mice

1 reference

12 December 2020

Use of thiazolidinediones and fracture risk

1 reference

12 December 2020

Bone marrow fat accumulation after 60 days of bed rest persisted 1 year after activities were resumed along with hemopoietic stimulation: the Women International Space Simulation for Exploration study.

1 reference

12 December 2020

PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis

1 reference

12 December 2020

Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation

1 reference

12 December 2020

Peroxisome proliferator-activated receptor alpha regulates B lymphocyte development via an indirect pathway in mice

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology

1 reference

12 December 2020

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

1 reference

12 December 2020

Regulation of bone mass by mechanical loading: microarchitecture and genetics.

1 reference

12 December 2020

Role of polyunsaturated fatty acids in the inhibitory effect of human adipocytes on osteoblastic proliferation

1 reference

12 December 2020

PPAR delta: a dagger in the heart of the metabolic syndrome

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma and metabolic disease.

1 reference

12 December 2020

Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone

1 reference

12 December 2020

Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways

1 reference

12 December 2020

The peroxisome proliferator activator receptor alpha/delta agonists linoleic acid and bezafibrate upregulate osteoblast differentiation and induce periosteal bone formation in vivo.

1 reference

12 December 2020

Bone as a target of type 2 diabetes treatment.

1 reference

12 December 2020

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)alpha agonist fenofibrate and the PPARgamma agonist pioglitazone

1 reference

12 December 2020

Enhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleen

1 reference

12 December 2020

An Osteoblast-dependent mechanism contributes to the leptin regulation of insulin secretion

1 reference

12 December 2020

Aging in adipocytes: potential impact of inherent, depot-specific mechanisms

1 reference

12 December 2020

PPARs and the complex journey to obesity

1 reference

12 December 2020

HMG-CoA reductase inhibitors and the risk of fractures

1 reference

12 December 2020

Leptin regulation of bone resorption by the sympathetic nervous system and CART

1 reference

12 December 2020

Bone is a target for the antidiabetic compound rosiglitazone.

1 reference

12 December 2020

Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation

1 reference

12 December 2020

Frequency of stromal lineage colony forming units in bone marrow of peroxisome proliferator-activated receptor-alpha-null mice

1 reference

12 December 2020

Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.

1 reference

12 December 2020

Fat and beyond: the diverse biology of PPARgamma

1 reference

12 December 2020

Bone marrow stromal stem cells: nature, biology, and potential applications

1 reference

12 December 2020

PPAR agonists modulate human osteoclast formation and activity in vitro

1 reference

12 December 2020

Fibrate therapy: an update

1 reference

12 December 2020

PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells

1 reference

12 December 2020

Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2.

1 reference

12 December 2020

Marrow changes in paraplegic patients

1 reference

12 December 2020

10.1007/S11914-010-0016-1

Identifiers

DOI

1 reference

22 August 2017

1 reference